RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 27 - per page Next page
Order by
Use of substituted or modified C60 fullerenes for the prevention or treatment of thrombosis, peripheral arterial occlusion, and catheter obstruction. More
Cancer immunotherapy using dendritic cells, and iii) Camel recombinant antibodies for FoxP3, Mucl & CEA. More
NexMed is developing RayVaTM, a topical treatment for Raynaud’s syndrome and incorporates alprostadil with the NexACT® proprietary permeation enhancer (DDAIP.HCL). More
Enhancing the dissolution performance of small and large molecules in a range of dosage forms More
Corticosteroid Microvesicles for Treatment of Cardiovascular Diseases More
Method for Inhibiting Angiogenesis using Heparinase More
Slowly-Released Nifedipine for Oral Administration More
Targeted Delivery to the Heart Endothelium: Applicable to Drug and Gene Delivery More
PPAP, A Novel Polymeric Gene Carrier System for Specific Artery Wall Gene Delivery More
Phase II Clinical Development of Trinam™: Prevention of the Blocking of Blood Vessels After Surgery More
Displaying 1..10 of 27 - per page Next page
Order by

Related Reports

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2012 Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us